Who dies from thin melanoma?

A E Cust¹

Affiliations

Comment

A E Cust. Br J Dermatol. 2020 Apr.

. 2020 Apr;182(4):827-828.

doi: 10.1111/bjd.18871. Epub 2020 Feb 3.

A E Cust¹

¹ Sydney School of Public Health and the Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.

No abstract available

Comment on

Clinicopathological factors associated with death from thin (≤ 1·00 mm) melanoma.
Claeson M, Baade P, Brown S, Soyer HP, Smithers BM, Green AC, Whiteman DC, Khosrotehrani K. Claeson M, et al. Br J Dermatol. 2020 Apr;182(4):927-931. doi: 10.1111/bjd.18560. Epub 2019 Nov 24. Br J Dermatol. 2020. PMID: 31562769

1. Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67:472-92.
1. Whiteman DC, Baade PD, Olsen CM. More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland. Australia. J Invest Dermatol 2015; 135:1190-3.
1. Landow SM, Gjelsvik A, Weinstock MA. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol 2017; 76:258-63.
1. Bell KJL, Mehta Y, Turner RM et al. Fear of new or recurrent melanoma after treatment for localised melanoma. Psychooncology 2017; 26:1784-91.
1. Claeson M, Baade P, Brown S et al. Clinicopathological factors associated with death from thin (≤ 1.00 mm) melanoma. Br J Dermatol 2020; 182:927-31.